Tag: Australian Medical Cannabis
BARRIE, Ontario, Jan. 31, 2020 (GLOBE NEWSWIRE) — MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) (“MediPharm Labs” or the “Company”) a global leader in specialized, research-driven cannabis...
The companies will continue to collaborate in the Australian market SMITHS FALLS, ON, Oct. 15, 2019 /PRNewswire/ – Canopy Growth Corporation (TSX: WEED) (NYSE: CGC) (“Canopy Growth”) has sold...
MediPharm Labs receives permits for additional Canadian exports of medical cannabis concentrate to Australia and completes related shipments Australian exports represent a 137% greater volume compared to first export...
TORONTO, ONTARIO / ACCESSWIRE / July 23, 2019 / MPX International Corporation (“MPX International”, “MPXI” or the “Company”) (CSE: MPXI; OTC PINK: MPXOF) is pleased to announce that it...
TORONTO, June 24, 2019 (GLOBE NEWSWIRE) — MediPharm Labs Corp. (TSXV: LABS) (OTCQX: MEDIF) (FSE: MLZ) (“MediPharm Labs” or the “Company”), a leader in specialized, research-driven cannabis extraction and...
MediPharm Labs Australia Awarded Cannabis Manufacturing Licence From Office of Drug Control – Establishes Asia-Pacific Foothold TORONTO, May 21, 2019 (GLOBE NEWSWIRE) — MediPharm Labs Corp. (TSXV: LABS) (OTCQX:...
KELOWNA, British Columbia and SYDNEY, Australia, April 18, 2019 (GLOBE NEWSWIRE) — Compass Cannabis Clinics (“Compass”), one of Canada’s fastest growing medicinal cannabis service providers, is pleased to announce...
Aphria’s Australian-based partner Althea receives Medical Cannabis License for cultivation Aphria maintains a 25% ownership interest in Althea and existing supply agreement LEAMINGTON, ON, March 15, 2018 /CNW/ –...
Indica Industries Pty Ltd, the partner of Canadian licensed producer MedReleaf (TSX: LEAF) (OTC: MEDFF) that is operating as MedReleaf Australia, has commenced commercial operations. The company, which received its...
ABCANN GLOBAL CORPORATION (TSXV: ABCN) (“ABcann” or the “Company”) is pleased to announce that its wholly-owned subsidiary, ABcann Australia Pty Ltd. (“ABcann Australia”), has received an import license from...
Canopy Growth enters landmark research and production MOU with Australian Victoria State Government SMITHS FALLS, ON and VICTORIA, Australia, Jan. 16, 2018 /CNW/ – Canopy Growth Corporation (TSX: WEED)...
Elixinol Global Initial Public Offering (“IPO”) Elixinol Global Limited (the “Company”) is pleased to announce the successful completion of its initial public offering (“IPO”) of shares and its admission...
Australia-based Creso Pharma (ASX: CPH) (OTC: CRCPF) announced an expansion into Colombia, signing a deal to acquire licensed medical cannabis company Kunna Canada and its wholly owned subsidiary, Kunna...
Aurora Cannabis Increases Ownership Interest in Cann Group Ltd. Cann to Use Funds for Accelerated Expansion Aurora’s Neil Belot Appointed to Cann Board of Directors VANCOUVER and EDMONTON, Dec....
Cann Group ( ASX: CAN) (OTC: CNGGF) announced an increase to its capital raise, boosting it to $58.7, seling by shares $2.50 in a deal underwritten by Canaccord...
Canopy Growth Provides Further International Updates SMITHS FALLS, ON, Sept. 13, 2017 /CNW/ – Canopy Growth Corporation (TSX: WEED) (OTC: TWMJF) (“Canopy Growth” or the “Company”) is pleased to...
Licensing & Distribution Agreement with Cannakorp for Cannabis Vaporization Technology 25 August 2017 – Cann Group Limited (ASX:CAN) has executed a licensing and distribution agreement with CannaKorp, Inc. to...
9 August 2017 Australian Manufacturing Licence Granted Significant milestone in Australian Operations AusCann has been granted an Australian medicinal cannabis manufacturing licence by the Office of Drug Control. The...
AusCann – Tasmanian Alkaloids Licenses Secured Australian medicinal cannabis licence, and a research and development licence, granted to AusCann’s strategic partner Tasmanian Alkaloids The licences are a significant milestone in...
AusCann Secures $12 Million In Institutional Placement 19 May 2017 Highlights Successful Placement raising $12 million with strong interest from new institutional investors both domestic and global 24,000,000 shares...
Readers of New Cannabis Ventures likely recall how we alerted to the huge opportunities in Canada last June, and the Canadian market continues to evolve as a leader in the...
Australia is a small but emerging medical cannabis market that has captured a lot of investor attention recently. Several publicly-traded companies have been rallying in 2017, and the first...
